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Polycomb group (PcG) proteins control the expres-
sion of genes important for cell-fate decisions and are
essential for embryogenesis, cell proliferation, and
stem cell self-renewal. The PcG proteins form multi-
protein complexes, called Polycomb repressive com-
plexes (PRCs). The PRC2 complex contains the PcG
proteins EZH2, SUZ12, and EED and is believed to
repress transcription through methylation of lysine (K)
27 of histone H3 (H3). All three PcG components of
the PRC2 complex are essential for the activity of the
complex and they are required for early mouse
embryogenesis.
In this chapter, we present some of the recent findings
regarding the role of PcG proteins and lysine demethy-
lases in embryonic stem cell differentiation, with the per-
spective of discussing models by which histone
methyltransferases and demethylases are involved in reg-
ulating transcription during stem cell maintenance and
cellular differentiation.
The development of a whole organism is a complex
process that requires the precise regulation of transcrip-
tion. Such regulation is essential to allow correct cellu-
lar commitment during development. Embryonic stem
(ES) cells are pluripotent cells derived from the inner
cell mass (ICM) of preimplantation embryos, which can
be indefinitely maintained in tissue culture and differ-
entiated into many different cell types (Keller 2005).
Thus, ES cells are powerful as a tool, not only to gener-
ate genetic mouse models, but also to study the molec-
ular mechanisms that regulate pluripotency and
differentiation. Furthermore, loss of cellular commit-
ment is a common feature of human cancers (Hanahan
and Weinberg 2000), and the delineation of the mecha-
nisms involved in regulating differentiation programs
therefore becomes important for understanding the
development of cancer.
THE POLYCOMB GROUP PROTEINS
The first PcG protein was discovered in Drosophila 60
years ago (Kennison 1995). The PcGs were defined as
factors that, when mutated, give phenotypes similar to
those of mutations in homeotic genes. This effect is coun-
teracted by mutations in the Trithorax group (TrxG) pro-
teins, which compete with the PcG proteins for binding to
the same DNA elements (Ringrose and Paro 2004). In
general, PcG proteins act as transcriptional repressors and
are required for maintaining the repressive state of
homeotic genes during fly development. The expression
of homeotic genes is set up by the activity of segmenta-
tion proteins. This occurs transiently in early develop-
ment, and the PcG and TrxG proteins maintain their
repression or activation, respectively, during later devel-
opment (Ringrose and Paro 2004). However, other results
have shown that PcG proteins are expressed and are asso-
ciated with homeotic genes earlier than the segmentation
proteins (Orlando et al. 1998), suggesting that the mecha-
nism by which fly development is regulated is more com-
plex than current models indicate.
PcG proteins are highly conserved during evolution,
and they execute their functions in multiprotein com-
plexes. The best-characterized PcG complexes are the
Polycomb repressive complexes 1 and 2 (PRC1 and
PRC2) (Francis and Kingston 2001; Simon and Tamkun
2002; Pasini et al. 2004a). Orthologs of PRC1 members
can be found in Drosophila to mammals, whereas
orthologs of the PRC2 complex are also found in nema-
todes and plants (Brock and Fisher 2005). The PRC1
complex contains several different subunits, and its com-
position can change in different cell types (Pasini et al.
2007; Puschendorf et al. 2008). The four Drosophila pro-
teins Pc, Psc, Ph, and dRING1 define the PRC1 core
(Francis et al. 2001). The PRC1 complex contains two
different enzymatic activities: Drosophila RING1
(RING1A and RING1B in mammals) catalyzes the ubiq-
uitylation of histone H2A and its loss of function leads to
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global loss of H2A K119 ubiquitylation in vivo (de
Napoles et al. 2004; Wang et al. 2004; Cao et al. 2005;
Stock et al. 2007; van der Stoop et al. 2008). Mammalian
CBX4 (one of five homologs of Drosophila Pc) is an E3
SUMO ligase that has been shown to catalyze the sumoy-
lation of the transcriptional repressor CtBP (Kagey et al.
2003, 2005). In vitro, the PRC1 complex retains the abil-
ity to bind in trans to nucleosomal arrays in a sequence-
independent manner (Lavigne et al. 2004) and to induce
compaction of nucleosomes (Francis et al. 2004). These
different activities of PRC1 suggest various mechanisms
by which PRC1 inhibits transcription.
The PRC2 complex is smaller than PRC1, and it is
composed of the three PcG proteins EZH2, EED, and
SUZ12 and the histone-binding proteins RbAp48/46.
Through its catalytic subunit EZH2, the PRC2 complex
preferentially methylates (me) K27 of histone H3 in vitro
(Cao et al. 2002; Czermin et al. 2002; Kuzmichev et al.
2002; Müller et al. 2002). However, different groups have
reported that PRC2 also can methylate histone H3K9 and
histone H1K26 in vitro (Czermin et al. 2002; Kuzmichev
et al. 2002, 2004; Erhardt et al. 2003; Su et al. 2003;
Pasini et al. 2004b), but so far, genetic models only pro-
vide support for the involvement of EZH2 in catalyzing
dimethylation and trimethylation of histone H3K27 in
vivo (Cao and Zhang 2004; Pasini et al. 2007;
Puschendorf et al. 2008; Riising et al. 2008). The activity
of the PRC2 complex is required for the association of
PRC1 to target genes (Cao et al. 2005; Pasini et al. 2007).
This might involve a mechanism by which PRC1 is
recruited to the H3K27me3 mark through direct binding
of the chromodomain containing the CBX component of
the PRC1 complex (Cao et al. 2002; Kuzmichev et al.
2002). Therefore, most current models of PcG-mediated
transcriptional repression involve, first, the recruitment of
the PRC2 complex to target genes, leading to methylation
of H3K27 and the subsequent recruitment of PRC1
through binding to H3K27me3. PRC1 recruitment results
in H2AK119 ubiquitylation (ubq) and chromatin com-
paction, resulting in a more stably transcriptional repres-
sive state. Despite the fact that this model requires further
experimental verification, the finding that PRC com-
plexes share most if not all target genes in different cell
types (Boyer et al. 2006; Bracken et al. 2006; Lee et al.
2006) strongly suggests that the two complexes have
coordinated functions and supports the repressive model
presented in Figure 1.
The components of the PRC2 complex are essential for
mouse embryonic development. Knockout embryos for
Ezh2, Eed, and Suz12 die during early postimplantation
stages during gastrulation (O’Carroll et al. 2001; Pasini et
al. 2004b; Montgomery et al. 2005). The generation of
mouse ES cell lines from Eed and Suz12 knockout preim-
plantation embryos has shown that PRC2 activity is dis-
pensable for the stem cell self-renewal but that Eed and
Suz12 knockout ES cells have an increased expression of
differentiation-specific genes and a tendency to differen-
tiate (Montgomery et al. 2005; Boyer et al. 2006; Lee et
al. 2006; Pasini et al. 2007; Chamberlain et al. 2008).
Attempts to derive Ezh2 knockout ES cell lines were
reported to be unsuccessful, suggesting that EZH2 is
required for ES cell self-renewal (O’Carroll et al. 2001).
The fact that both Eed and Suz12 knockout ES cells glob-
ally lose H3K27me2/3 might suggest that Ezh2 has
PRC2-independent functions that do not involve H3K27
methylation.
Interestingly, the analyses of ES cell differentiation of
Suz12 and Eed knockout ES cells have shown that the
proteins are required for proper differentiation. The lack
of differentiation correlates with failure to activate lin-
eage-specific genes and to repress genes involved in stem
cell self-renewal (Pasini et al. 2007; Chamberlain et al.
2008). These results are in agreement with the early
developmental defects in PRC2 knockout embryos and
show that the PRC2 proteins are critical for cell-fate
determination during development.
Differently from PRC2, mice with mutations in genes
of the PRC1 complex have less pronounced embryonic
defects. For example, Bmi1 (Psc inDrosophila) knockout
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Figure 1. Proposed model for the mechanism by which
Polycomb group proteins regulate their target genes. First, the
PRC2 complex is recruited by ill-defined transcription factors,
leading to the methylation of histone H3K27. This methylation
results in the recruitment of the PRC1 complex through the bind-
ing to methylated K27. Subsequently, the RING1B protein of the
PRC1 complex catalyzes the ubiquitylation of histone H2A
K119, which may lead to chromatin compaction.
mice die at birth with pronounced neural and hematopoi-
etic defects (van der Lugt et al. 1994). This result could
appear at odds with the proposed coordinated regulation
of PRC2 and PRC1 repressive activities, but it is most
likely a result of functional redundancy between the
PRC1 subunits (Bmi1 has, for instance, five homologs in
mice). In agreement with this, the inactivation of Rnf2
(Ring1B, dRING1 in Drosophila), which has only one
homolog (Ring1a), leads to embryonic lethality in early
postimplantation stages in mice, demonstrating that lack
of PRC1 enzymatic activity is indeed essential for embry-
onic development (Voncken et al. 2003). Although Rnf2
knockout ES cells show global loss of H2A ubiquitylation
and have an increased expression of differentiation-spe-
cific genes, they can be established, similarly to ES cells
devoid of PRC2 activity (de Napoles et al. 2004; Stock et
al. 2007; Endoh et al. 2008; van der Stoop et al. 2008).
Taken together, these data imply a crucial role for Rnf2 in
PRC1 function and support the functional overlap
between PRC1 and PRC2.
PCG TARGET GENES
Many aspects of PcG transcriptional regulation are still
not fully understood. This includes the signaling path-
ways that control PRC2 activity, factors that mediate PcG
recruitment to target genes, molecular mechanisms by
which PcG inhibits transcription, and downstream path-
ways regulated by the PcG proteins. The identification of
direct target genes of the PcG proteins within the last cou-
ple of years has significantly extended our knowledge
regarding the downstream pathways regulated by the PcG
proteins and, at the same time, has provided us with the
tools to unravel the mechanism by which PcG proteins
regulate transcription. Genome-wide location analyses
using chromatin immunoprecipitation (ChIP) of PcG pro-
teins and H3K27me3 in different cells lines, including
mouse and human ES cells, have led to the following
observations:
1. PcG and H3K27me3 are mainly associated with tran-
scriptional start sites (TSS) of genes (Lee et al. 2006). In
contrast to this,Drosophila PcG proteins are also found
to be associated with Polycomb responsive elements
(PREs) located several kilobases from the TSS
(Ringrose and Paro 2004). This may suggest that the
mechanism by which PcG proteins control transcription
is not conserved between Drosophila and mammals.
2. The PcG proteins bind directly to the promoters of a
large number of important regulators controlling cell-
fate decisions during development in both human and
mouse ES cells as well as in human embryonic fibro-
blasts (hEF) (Boyer et al. 2006; Bracken et al. 2006;
Lee et al. 2006). The studies have shown that the PcGs
are associated with the TSS of entire gene families,
including homeobox, Gata, Pax, Sox, Wnt, Fgf, and
T-box genes. These findings suggest a model by
which the PcG proteins are displaced from their target
genes when cells differentiate and that this displace-
ment is required for the correct expression of lineage-
specific genes.
3. PcG target genes are not fully conserved in different
cell types. Comparison between cell lines such as ES,
mouse embryonic fibroblast (MEF), C2C12
myoblasts, and hEF has shown that a proportion of
PcG target genes are not conserved. Perhaps, not so
surprisingly, PcG target genes show the largest degree
of difference between normal and cancer cells
(Bernstein et al. 2006a; Boyer et al. 2006; Bracken et
al. 2006; Lee et al. 2006; Squazzo et al. 2006;
Mikkelsen et al. 2007; Mohn et al. 2008). This differ-
ence could be partly flawed if the cancer cells are not
compared to their normal counterparts, i.e., the cell of
origin for the tumor cells. However, more intriguingly,
the observed differences could be a result of the trans-
formation process. Interestingly, despite the low
degree of overlap between normal and tumor cells,
PRC2 activity is essential for the proliferation of all
cells tested so far, and it does not exclusively depend
on the ability of PcG proteins to repress the INK4A-
ARF locus (Bracken et al. 2003; Pasini et al. 2004b).
4. Different models describing how the PcG proteins reg-
ulate their target genes during differentiation have
been proposed. We and other investigators have
shown that PcG proteins are displaced from promoters
when ES cells undergo differentiation. Moreover, the
PcGs are also actively recruited to a substantial num-
ber of genes during differentiation (Bracken et al.
2006; Pasini et al. 2007; Mohn et al. 2008).
Surprisingly, we have also found that the PcG proteins
accumulate on some genes, even though they are acti-
vated, during differentiation (Pasini et al. 2007).
Taking into consideration that ES cells do not differ-
entiate synchronously, these results could suggest
either that PcG activity is required for the transcrip-
tional activation of some target genes or that, in some
cases, the binding of the PcG proteins does not exclude
transcription and may instead predispose the target
genes for repression in later differentiation stages.
Some support for the first hypothesis is provided by
the fact that the activation of these genes does not
occur in Suz12 knockout ES cells (Pasini et al. 2007);
however, this may also be due to the lack of proper dif-
ferentiation of these cells. The second hypothesis is
supported by the fact that transcribed genes such as
NEUROG2 and OLIG2 are bound by PcGs and
enriched for H3K27me3 in NT2 embryonic teratocar-
cinoma cells (Bracken et al. 2006).
We have summarized the different models for how the
PcG proteins regulate transcription in Figure 2. Whereas
solid evidence supports both the derepression and the
recruitment models, further studies using differentiation
systems with highly pure cellular populations combined
with ChIP–re-ChIP (reverse ChIP) approaches are
required to validate the activation model.
DOWNSTREAM FROM THE PCG PROTEINS
As previously mentioned, PcGs associate with the pro-
moters of several genes whose activities are required for
cell-fate determinations during development (Boyer et al.
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2006; Bracken et al. 2006; Lee et al. 2006). Among these,
some deserve particular considerations.
The PcG proteins control expression of theHOX genes.
They are bound to all four HOX gene clusters in ES cells
(Boyer et al. 2006; Lee et al. 2006), and the use of tiling
arrays in hES cells demonstrated that PcGs and
H3K27me3 spread throughout the entire cluster (Lee et al.
2006). Interestingly, similar experiments in committed
hEF cells showed that the 3′ end of all clusters lose PcG
association and H3K27me3 (Bracken et al. 2006). Similar
to their requirement in fly development, the HOX proteins
are indispensable for mammalian development. Their
spatial and temporal expression is essential and requires a
tight regulation throughout development (Wellik 2007).
Several results have suggested that PcGs are required for
maintaining all HOX genes silenced in pluripotent cells
and that differential PcG dissociation from HOX genes
may be required for the coordinated regulation of HOX
expression during development (Cao et al. 2005; Boyer et
al. 2006; Bracken et al. 2006).
Another group of transcription factors regulated by the
PcG proteins are the GATA factors. These transcription
factors have different roles in development, and whereas
GATA1, -2, and -3 are essential in hematopoiesis
(Bresnick et al. 2005), GATA4, -5, and -6 seem to be
required for myocardial development (Laverriere et al.
1994). Interestingly, the loss of PcGs in ES cells results in
increased levels of GATA3, -4, and -6 (Boyer et al. 2006).
This result further suggests an important role for PcG pro-
teins in GATA repression, and consistent with this, the
tissue-specific inactivation of Ezh2 leads to B- and T-cell
developmental defects (Su et al. 2003, 2005).
PcG proteins directly associate with the promoters of
several members of other transcription factor families
such as the SRY box (SOX), T-box (TBX), forkhead box
(FOX), and paired box (PAX) genes that have essential
roles in regulating different developmental processes
(Carlsson and Mahlapuu 2002; Plageman and Yutzey
2005; Kiefer 2007; Lang et al. 2007). Moreover, PcGs
also associate with the promoters of gene families
involved in different signaling pathways, including
genes involved in transforming growth factor-β (TGF-β),
WNT, and fibroblast growth factor (FGF) signaling.
These signaling pathways regulate development by act-
ing on cell-fate, patterning, and mitogenic signals
(Kitisin et al. 2007; Cohen et al. 2008; Hayward et al.
2008; Itoh and Ornitz 2008).
Finally, our studies have demonstrated that PcG pro-
teins directly bind and repress the INK4A-ARF tumor
suppressor locus (Bracken et al. 2007). This locus codes
for the expression of two negative regulators of the cell
division cycle: p16INK4A and p14ARF (p19ARF in mouse).
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Figure 2.Model for the potential mechanisms by which the PcG proteins regulate transcription during differentiation. (A) Schematic
representation of the derepression model, suggesting that displacement of PcG-binding contributes to the lineage-specific expression
of target genes. (B) Schematic representation of the repression model, suggesting that PcGs can be actively recruited to the promoters
of lineage-specific genes during differentiation. (C) Schematic representation of the activation model, showing that PcGs can be
recruited to specific target genes that undergo transcriptional activation during differentiation. The model further highlights the fact
that PcG recruitment may predispose these target genes for repression in later differentiation stages.
p16INK4A inhibits CDK4/CDK6 activity, and therefore
phosphorylation of members of the retinoblastoma pro-
tein pRB family, whereas p14ARF inhibits the activity of
MDM2, thereby leading to the accumulation of p53.
Elevated levels of both p16INK4A and p14ARF expression
lead to cell cycle arrest (Sherr 1998; Lowe and Sherr
2003). Importantly, activation of p16INK4A and p14ARF
expression as a result of oncogene activation, oxidative
stress, or other types of stress signals correlates with the
displacement of the PcG proteins and decreased levels
of H3K27me3 from the INK4A-ARF locus (Bracken et
al. 2007). Consistent with a causal role of PcG proteins
in the regulation of the locus, both genetic inactivation
and RNA interference (RNAi)-based depletion of differ-
ent PcG members induce premature senescence,
whereas overexpression of PcG proteins such as BMI1,
EZH2, CBX7, and CBX8 prevents stressed-induced
senescence in an INK4A-ARF–dependent manner
(Jacobs et al. 1999; Bracken et al. 2003, 2007; Gil et al.
2004; Dietrich et al. 2007). Importantly, the regulation
of cell proliferation through binding to the INK4A-ARF
locus is an essential feature of PcG proteins in mam-
malian cells, as first illustrated by the remarkable obser-
vation that several phenotypes of Bmi1–/– knockout mice
are rescued by con- comitant deletion of the Ink4a-Arf
locus (Jacobs et al. 1999; Bruggeman et al. 2005;
Molofsky et al. 2005). These results also show that PcG
proteins regulate embryonic development and normal
differentiation by controlling both cell proliferation and
the expression of a large number of genes involved in
cell-fate decisions.
MECHANISMS FOR PCG
TRANSCRIPTIONAL REGULATION
Although understanding of the downstream regulatory
pathways regulated by PcG proteins is becoming clearer,
two other aspects of PcG regulation are still poorly under-
stood. First, the mechanisms by which PcGs are recruited
to their target genes in mammalian cells remain elusive,
and second, it is not fully understood how the PcG pro-
teins repress transcription.
In Drosophila, the transcription factors Gaga, Psq,
Zeste, Pho, and Pho-like (PhoL) mediate PcG recruitment
to PREs (Brown et al. 2003). A PRE consists of multiple
binding sites for these transcription factors, and it is
believed that a PRE is defined by a combination of these
binding sites. An algorithm to predict Drosophila PREs
has been designed and has successfully predicted novel
PREs (Ringrose et al. 2003; Ringrose and Paro 2007).
This algorithm cannot predict any putative PREs from
mammalian genomes and, together with the ChIP-chip
data (Lee et al. 2006; Mikkelsen et al. 2007), suggests that
these elements are not conserved.
Homologs for the transcription factors binding the
Drosophila PREs are, with the exception of Pho, not
found in mammals. Pho is homologous to the mammalian
transcription factor Yin Yang 1 (YY1) (Brown et al.
1998). Consistent with this, it was shown that Yy1 and
Ezh2 interact and colocalize to the Mhc2b promoter in
undifferentiated C2C12 myoblasts (Caretti et al. 2004).
The fact that YY1 has not been reported to copurify with
the PRC complexes could suggest that the association
between YY1 and the PRCs is not stable (Cao et al. 2002;
Czermin et al. 2002; Kuzmichev et al. 2002; Müller et al.
2002). Importantly, Yy1 knockout mice are not viable and
are embryonic-lethal in early postimplantation stages,
similar to Ezh2, Eed, Suz12, and Rnf2 knockout embryos
(Donohoe et al. 1999). This result supports the possibility
of a functional link between Yy1 and PRC complexes.
Thus, it appears that the identification of target genes for
YY1 in different cell types by genome-wide techniques is
important for understanding the extent of overlap between
YY1 and PcG proteins.
As described above, recent ChIP-chip and ChIP-
sequencing (ChIP-seq) studies have led to the identifica-
tion of PcG-associated DNA sequences (Boyer et al.
2006; Bracken et al. 2006; Lee et al. 2006; Mikkelsen et
al. 2007). On the basis of these studies, it should be pos-
sible to identify DNA sequences or elements that function
as PREs in mammalian cells. However, so far, no studies
have been published in which a mammalian PRE has been
identified. This could suggest that PREs do not exist or
that there are many different PREs containing DNA-bind-
ing sites for a number of different transcription factors.
The existence of a large number of PREs would allow the
PcGs to differentially regulate gene expression depending
on cell-type specification. Supporting a role for specific
transcription factors in the regulation of PcG target genes
is the recent demonstration that the transcription factor
Snail1 recruits the PRC2 complex to the E-cadherin pro-
moter to repress its expression in the mesoderm of devel-
oping mouse embryos (Herranz et al. 2008). Consistent
with this, PcG target genes diverge when comparing dif-
ferent cell types (Squazzo et al. 2006; Mohn et al. 2008).
How do PcGs regulate transcription? As we have dis-
cussed above, PcG binding mainly correlates with tran-
scriptional silencing (Boyer et al. 2006; Lee et al. 2006;
Mikkelsen et al. 2007). Forced recruitment of the PRC2
complex to an artificial promoter induces transcriptional
repression and suggests that PcGs “by default” act as tran-
scriptional repressors (Pasini et al. 2008). However, as
discussed previously, PcGs also associate with promoters
that are actively transcribed, suggesting that PcG-medi-
ated transcriptional regulation is a complex process that
likely involves different mechanisms and factors. If we
only consider the repressive activity of the PRC com-
plexes, it is not fully understood how PcG recruitment can
negatively influence transcription. First of all, it has not
been formally established that the catalytic activity and
therefore the H3K27me3 mark are required for PRC2
function. Results from several laboratories, including
ours, have shown that the growth-promoting and onco-
genic effects of EZH2 depend on the presence of a func-
tional SET domain (Bracken et al. 2003; Kleer et al.
2003). This suggests that K27 methylation is essential for
PcG activity, but the fact that these studies are based on
the use of a truncated form of EZH2 still leaves the ques-
tion open. Mechanistically, it has been proposed that
H3K27me3 serves as a docking site for PRC1 recruitment
and that this leads to ubiquitylation of H2AK119 and to
compaction of chromatin (Francis et al. 2004; Cao et al.
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2005). These observations may suggest that PRC com-
plexes repress transcription by preventing the binding of
FACT, thereby leading to a block of RNA-polymerase-
II–dependent elongation (Zhou et al. 2008).
The physiological role of H3K27me3 in recruiting the
PRC1 complex is also not fully understood. Even though
PRC2 is required for the recruitment and maintenance of
PRC1 on promoters (Cao et al. 2005; Boyer et al. 2006;
Pasini et al. 2007), biochemical studies have shown that
chromodomains of CBX proteins, which are part of dif-
ferent PRC1 complexes, have relatively low binding
affinity for methylated lysines (Kd in a higher micromolar
range) and, in addition, do not appear to discriminate
between H3K9 and H3K27 trimethylation (Bernstein et
al. 2006b). Thus, although these studies have been per-
formed in vitro, they suggest that binding of CBX pro-
teins to trimethyl lysines is unlikely to be the only
mechanism by which PRC1 complexes are recruited to
target genes. In agreement with this interpretation is the
demonstration that the swap of chromodomains between
HP1 and Pc is not sufficient to completely relocalize these
proteins to other genes/structures in the cell (Platero et al.
1995). Taken together, these results suggest that the
PRC1 complexes contain domains other than the chro-
modomains of the CBX proteins that are essential for their
recruitment to PcG target genes.
Once PRC1 is recruited to its target gene, it is believed
to maintain transcriptional repression. The question is
how this is achieved. The PRC1 complex contains two
different enzymatic activities. RING1B catalyzes the
ubiquitylation of H2AK119 (Wang et al. 2004), whereas
CBX4 contains E3 SUMO ligase activity (Kagey et al.
2003). How these two activities are related to the ability
of PRC1 to repress transcription is currently unknown.
However, the PRC1 complex has the ability to compact
nucleosomes in vitro, suggesting that the complex could
create a less-accessible chromatin environment at target
genes (Francis et al. 2004). It is possible that such an
effect will exclude RNA polymerase II from PcG target
genes, but the fact that PcG binding in Drosophila does
not exclude RNA polymerase II association to some pro-
moters (Breiling et al. 2001) and that 23% of Suz12 tar-
get genes in hES cells have polymerase II associated with
their promoter (Lee et al. 2006) does not support such a
mechanism.
In this connection, it is important to note that loss of
PcG activity only leads to the transcriptional activation of
a small subset of target genes (Boyer et al. 2006; Bracken
et al. 2006; Lee et al. 2006). Moreover, this activation is
relatively low when compared with the expression levels
that are achieved during normal activation of PcG target
genes. An example of this is illustrated in Figure 3A.
Here, the expression levels of Gata4 and Tbx1 are shown
to be significantly higher during ES cell differentiation
compared to their expression levels in Suz12–/– ES cells.
These observations suggest that PcG displacement from
promoters during differentiation is required, but not suffi-
cient, for efficient activation of transcription and propose
that in ES cells, the transcription factors required for this
activation are either not expressed or their recruitment is
impaired by a PcG-independent mechanism. This inter-
pretation is further supported by genome-wide studies
(summarized in Fig. 3B–D) showing that a large propor-
tion of PcG target genes present higher transcript levels
during differentiation when compared to loss of PcG
activity. The existence of different layers of transcrip-
tional regulators to control the expression of the same
gene is in agreement with the complex spatial and tempo-
ral transcription network that must be established to regu-
late proper development of an organism.
HISTONE METHYLATION AND
DEMETHYLATION
The recent discovery of lysine demethylases (KDM)
that can actively remove methylation groups from lysine
residues has increased the complexity of transcriptional
regulation even further. Until the discovery of LSD1, his-
tone lysine methylation was believed to be a stable mark
that could only be lost during DNA replication and/or by
histone replacement. LSD1 can catalyze the demethyla-
tion of me1 and me2 groups but not me3 groups (Shi et al.
2004). For this reason, me3 groups were considered a sta-
ble modification until the recent discovery that Jumonji
C domain (JmjC)-containing proteins can actively
remove me3 groups. This includes KDMs specific for
H3K9me3/me2/me1, H3K36me3/me2, H3K27me3/me2,
and H3K4me3/me2. Several of these KDMs are impor-
tant for transcriptional regulation and are involved in dif-
ferent physiological processes, including differentiation
and development (Agger et al. 2008; Cloos et al. 2008).
For example, Jmjd1a (H3K9me2/me1-specific) and
Jmjd2c (H3K9me3/me3- and H3K36me3/me2-specific)
have been reported to be required for the pluripotency of
mouse ES cells, potentially involving a mechanism
removing H3K9me3 from the Oct4 promoter and thereby
preventing its transcriptional repression (Loh et al. 2007).
We and other investigators have shown that members
of the JARID1 family specifically catalyze the demethy-
lation of H3K4me3/me2 and that they are important for
normal development (Christensen et al. 2007; Iwase et al.
2007; Klose et al. 2007; Lee et al. 2007a; Yamane et al.
2007). Recently, we have addressed the functional role of
one member of the Jarid1 family (Rbp2/Jarid1a) in
mouse ES cells (Pasini et al. 2008). By promoter location
analysis, we have shown that Rbp2 is bound at the pro-
moter of a large number of differentiation-related genes,
suggesting that this activity may be involved in the
repression of these genes in ES cells. In addition, we
have demonstrated that Rbp2 and the PRC2 complex
have a large number of common target genes, that Rbp2
and PRC2 interact, and that Rbp2 is required for the
maintenance of the repression of PcG target genes
(Pasini et al. 2008). These results show that the coordi-
nated regulation of histone modifications by a repressive
complex, containing KMT and KDM activities, may be
important for the transcriptional regulation of different
genes during differentiation and development.
Interestingly, similar biochemical structures containing
KMT and KDM activities have also been reported for the
TrxG-like MLL complex, where the MLL2 and ASH2
H3K4me3 KMTs are associated in a complex containing
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the H3K27me3-specific demethylase UTX (Agger et al.
2007; Issaeva et al. 2007; Lee et al. 2007b). These find-
ings indicate that these different enzymatic activities
function together to coordinately regulate lysine methy-
lation and transcription. Moreover, they suggest that
antagonistic activities act reciprocally during differentia-
tion to regulate the “on” and “off” state of gene expres-
sion (Fig. 4).
BIVALENT DOMAINS:
AN ES CELL FEATURE?
Recent studies using genome-wide tiling ChIP-chip
and ChIP-seq approaches for different methylated
residues of histone tails have identified a modification
pattern in ES cells termed “bivalent domains,” consist-
ing of H3K4me3 and H3K27me3 on the same nucleo-
somes (Bernstein et al. 2006a). Despite the considerable
number of H3K4me3-positive promoters in ES cells
(78% of total annotated promoters), a large proportion of
H3K27me3-positive promoters are also H3K4me3-posi-
tive (96% of Suz12 promoters) (Mikkelsen et al. 2007).
This correlation is statistically significant (probability
value = 1.4E–18), suggesting a functional role for the
coexistence on these modifications. Interestingly, biva-
lent promoters correlate with low levels of expression,
and bivalent domains are often lost in committed lin-
eages (Mikkelsen et al. 2007; Mohn et al. 2008).
Maintenance of H3K4me3, but not H3K27me3, corre-
lates with activation of expression of bivalent genes in
committed cell lines, suggesting that bivalency in ES
cells has the function to maintain genes in a poised state
for activation (Mikkelsen et al. 2007). This observation
is extremely interesting and agrees with the transcrip-
tional plasticity of pluripotent ES cells. Despite this, dif-
ferent questions in this regard remain unanswered. For
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Figure 3.Different activities are required for the transcriptional regulation of PcG target genes during differentiation. (A)Gata4 and Tbx1
transcription in wild-type, Suz12–/–, and differentiated wild-type mouse ES cells, showing that loss of PcG activity in ES cells is not suf-
ficient for obtaining the full transcriptional activation achieved during ES cell differentiation (Pasini et al. 2007; D. Pasini, unpubl.). (B)
Summary table obtained from genome-wide studies (Boyer et al. 2006; Lee et al. 2006), showing the proportion of PcG target genes that
undergo transcriptional activation during mouse ES cell differentiation. (C) Summary table obtained from genome-wide studies (Boyer
et al. 2006; Lee et al. 2006) showing the proportion of PcG target genes that undergo transcriptional activation in Suz12–/– ES cells. (D)
Summary table obtained from genome-wide studies (Boyer et al. 2006; Lee et al. 2006), showing the proportion of PcG target genes that
undergo transcriptional activation during mouse ES cell differentiation and in Suz12–/– ES cells. Similar to the data presented in A, this
table shows that a large proportion of PcG target genes that are activated during differentiation and in Suz12–/– ES cells present higher
transcript levels during differentiation relative to loss of Suz12 activity (58%with a stringent cutoff or 81%with a low cutoff). “Up 2-fold
more in differentiation” includes genes that have a twofold higher expression level during differentiation versus Suz12–/– ES cells. “Down
2-fold more in differentiation” includes genes that have a twofold lower expression level during differentiation relative to Suz12–/– ES
cells. “Less than 2-fold change” includes genes with expression changes lower than twofold during differentiation relative to Suz12–/– ES
cells. “Up more in differentiation” includes genes that have a higher expression level during differentiation relative to Suz12–/– ES cells.
“Down more in differentiation” includes genes that have a lower expression level during differentiation relative to Suz12–/– ES cells. “No
changes” includes genes that have no expression changes during differentiation relative to Suz12–/– ES cells.
example, is the bivalent mark important for transcrip-
tional activation? What is the relevance for the bivalent
mark at the CpG-rich promoter (HCG) if they are virtu-
ally all H3K4me3 (Mikkelsen et al. 2007)? Moreover,
Bernstein and colleagues have suggested that most biva-
lent genes in ES cells resolve in committed cells, sug-
gesting that bivalency is a specific feature of ES cells;
however, recent data have shown that together with
a proportion of genes that lose bivalency, there is a sim-
ilar proportion of genes that gain bivalency during dif-
ferent stages of ES cell differentiation, demonstrating
that bivalency is a feature not only of ES cells, but also
of different committed cells types (Mohn et al. 2008).
Additional work is required to better address the role of
bivalent domains in regulating transcription during
development.
The presence of bivalent domains may seem to be in
contrast with our findings that PcG proteins coexist on a
large number of PcG target genes with the H3K4
demethylase Rbp2 (Pasini et al. 2008). However, the
association of Rbp2 with promoters does not appear to
“erase” H3K4me3 from promoters but likely associates
with the PRC2 complex to “fine-tune” the levels of
H3K4me3 at TSS. Loss of Rbp2 activity leads to
increased H3K4me3 levels, induces transcriptional acti-
vation, but does not affect PRC2 binding or H3K27me3
levels (Pasini et al. 2008). This interpretation is further
supported by data that the H3K27me3 demethylase UTX
is associated with promoters that are trimethylated on his-
tone H3K27 (Agger et al. 2007; Lee et al. 2007b).
PCGS AND DNA METHYLATION
The methylation of a DNA cytosine residue within a
CpG dinucleotide is an important mechanism for inher-
ited epigenetic silencing of gene expression. CpG dinu-
cleotides are found all over the genome, but they
accumulate with high frequency in the proximity of TSS.
These clusters of CpGs are defined as CpG islands. The
hypermethylation of CpG islands leads to transcriptional
repression (Bird 2002). DNA methylation is believed to
be a stable modification that is inherited through many
cell divisions, even a lifetime in the case of the inactivated
X chromosome. In agreement with this, DNA methyla-
tion is faithfully inherited during DNA replication, and no
bona fide DNA demethylase has so far been identified.
Recent data have shown that very few CpG islands are
methylated in ES cells (Meissner et al. 2008). This is not sur-
prising, because ES cells can differentiate into many differ-
ent cell types and therefore require high transcriptional
flexibility. Because DNA methylation is a stable modifica-
tion, it will restrict the developmental potential of ES cells.
In contrast, in terminally differentiated cells, which require
low levels of plasticity and hence a stable expression pro-
gram, many promoters are DNA-methylated. This DNA
methylation, which is essential for differentiation, is
acquired during the differentation process. The enzymes that
catalyze DNA methylation belong to the DNMT protein
family (Bird 2002). Recently, it was shown that PcGproteins
are able to interact with all members of the DNMT family,
and it was suggested that PcGs and DNMTs are dependent
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Figure 4. A model for the coordinated regulation of transcription by histone methyltransferases and demethylases during differentia-
tion. The model highlights the antagonistic recruitment of repressive and activator complexes to regulate transcription during differ-
entiation. The activator and repressive complexes contain opposite enzymatic activities. The repressive complex is formed by PRC2
H3K27 KMT activity, RBP2 H3K4 KDM activity, and HDAC de-acetylase activity, whereas the activator complex is formed by MLL
H3K4 KMT activity, UTX H3K27 KDM activity, and HAT acetyltransferase activity. Furthermore, the model stresses that recruit-
ment of the complexes could be mediated by multiple uncharacterized transcription factors.
on each other for their recruitment to target promoters (Vire
et al. 2006). These results are also interesting in the perspec-
tive of tumor development. Promoter DNA hypermethyla-
tion frequently silences tumor suppressor genes, whereas
members of the PRC2 complex are overexpressed in many
human tumors. Taken together, these findings suggest a
mechanism that links PcG overexpression to promoter
hypermethylation in the development of human cancer.
However, the mechanism by which PcGs set up and main-
tain DNA methylation is still under debate because other
publications have suggested that RNAi-based PcG depletion
does not reactivate the expression of fully methylated genes
(McGarvey et al. 2007) and that trimethylation of histone
H3K27 is an alternative mechanism for repressing tumor
suppressor genes in prostate cancer, which does not require
DNA methylation (Kondo et al. 2008). Nevertheless,
genome-wide studies in primary and cancer cell lines have
shown that there is a significant correlation between being a
PcG- and H3K27me3-enriched gene in ES cells and differ-
entiated cells and becoming DNA-hypermethylated in can-
cer cells (Schlesinger et al. 2007;Widschwendter et al. 2007;
Mohn et al. 2008). Moreover, consistent with an essential
role of PcGs to repress genes instructive for cell-fate deci-
sions, recent results have demonstrated that low expression
of PcG target genes contributes significantly to an embryonic
stem-cell-like gene expression signature in poorly differenti-
ated aggressive human tumors (Ohm et al. 2007).
CONCLUDING REMARKS
In this symposium review, we have summarized the
recent advances in understanding how histone methylation
regulates pluripotency. In particular, we have focused on
the role of Polycomb group proteins in regulating tran-
scription during development. We have discussed several
models by which they control gene expression, how they
are recruited to their sites of action, and a number of other
unresolved questions that will be extremely interesting to
address in the future. This is an exciting field that moves
very quickly, and we expect that many of the questions we
have posed will be solved within the next few years.
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